SIRNAOMICS-B(02257): Lu Yang resigns as non-executive director
Shengnuo Pharmaceutical-B (02257) announced that the board of directors has received the resignation letter from Dr. Luyang (Dr. Lu) due to...
SIRNAOMICS-B (02257) Announcement Board, the Board has received Dr. Lu Yang's (Dr. Lu) resignation letter. Due to Dr. Lu's desire to devote more time to other matters, he has resigned as a non-executive director, a member of the Board Nomination Committee, the Honorary Chief Scientific Officer of the group, and the authorized representative of the company under Rule 3.05 of the Listing Rules of the Hong Kong Stock Exchange, effective from February 5, 2025. Dr. Lu has been appointed as the Honorary Scientific Advisor of the group, effective from February 5, 2025.
The Board further announces that after Dr. Lu's resignation as a non-executive director, a member of the Nomination Committee, Honorary Chief Scientific Officer of the group, and authorized representative, Ms. Huang Mengying (Ms. Huang) has been appointed as a member of the Nomination Committee and authorized representative, effective from February 5, 2025.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


